Can a novel computerized cognitive screening test provide additional information for early detection of Alzheimer's disease?

Alzheimer's and Dementia

Volumn 10, Issue 6, 2014, Pages 790-798

  Tarnanas, Ioannis ^a,b   Tsolaki, Magda ^c   Nef, Tobias ^a,d   M Müri, René ^a,e   Mosimann, Urs P ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF ULM   (Germany)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d UNIVERSITY OF BERN   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

Author keywords

Computerized cognitive assessment; Computerized testing; Dementia; Early detection; Psychometrics

Indexed keywords

BIOLOGICAL MARKER;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); DISEASE COURSE; EARLY DIAGNOSIS; EVENT RELATED POTENTIAL; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE MEMORY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SHORT TERM MEMORY; TASK PERFORMANCE; VIRTUAL REALITY; WORKING MEMORY; ANALYSIS OF VARIANCE; COGNITION; COGNITION DISORDERS; COMPLICATION; COMPUTER ASSISTED DIAGNOSIS; COMPUTER INTERFACE; DAILY LIFE ACTIVITY; ELECTROENCEPHALOGRAPHY; PHYSIOLOGY; PSYCHOLOGY; VERY ELDERLY;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; COGNITION; COGNITION DISORDERS; DIAGNOSIS, COMPUTER-ASSISTED; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; USER-COMPUTER INTERFACE;

EID: 84927178089     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2014.01.002     Document Type: Article

References (50)

1. L.E. Hebert, P.A. Scherr, L.A. Beckett, M.S. Albert, D.M. Pilgrim, and M.J. Chown Age-specific incidence of Alzheimer's disease in a community population JAMA 273 1995 1354 1359
2. W.A. Kukull, R. Higdon, J.D. Bowen, W.C. McCormick, L. Teri, and G.D. Schellenberg Dementia and Alzheimer disease incidence: a prospective cohort study Arch Neurol 59 2002 1737 1746
3. R. Brookmeyer, D.A. Evans, L. Hebert, K.M. Langa, S.G. Heeringa, and B.L. Plassman National estimates of the prevalence of Alzheimer's disease in the United States Alzheimers Dement 7 2011 61 73
4. F. Matthews, and C. Brayne The incidence of dementia in England and Wales: findings from the five identical sites of the MRC CFA Study PLoS Med 2 2005 e193
5. R.C. Petersen Mild cognitive impairment clinical trials Nat Rev Drug Discov 2 2003 646 653
6. S. Borson, L. Frank, P.J. Bayley, M. Boustani, M. Dean, and P.-J. Lin Improving dementia care: the role of screening and detection of cognitive impairment Alzheimers Dement 9 2013 151 159
7. R.C. Petersen, J.E. Parisi, D.W. Dickson, K.A. Johnson, D.S. Knopman, and B.F. Boeve Neuropathologic features of amnestic mild cognitive impairment Arch Neurol 63 2006 665 672
8. R.C. Petersen, R.O. Roberts, D.S. Knopman, B.F. Boeve, Y.E. Geda, and R.J. Ivnik Mild cognitive impairment: ten years later Arch Neurol 66 2009 1447 1455
9. M.S. Albert, S.T. DeKosky, D. Dickson, B. Dubois, H.H. Feldman, and N.C. Fox The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 270 279
10. A.S. Khachaturian, M.M. Mielke, and Z.S. Khachaturian Biomarker development: a population-level perspective Alzheimers Dement 8 2012 247 249
11. P. Buchhave, L. Minthon, H. Zetterberg, A.K. Wallin, K. Blennow, and O. Hansson Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia Arch Gen Psychiatry 69 2012 98 106
12. P.N. Wang, J.F. Lirng, K.N. Lin, F.C. Chang, and H.C. Liu Prediction of Alzheimer's disease in mild cognitive impairment: a prospective study in Taiwan Neurobiol Aging 27 2006 1797 1806
13. P. Vemuri, H.J. Wiste, S.D. Weigand, L.M. Shaw, J.Q. Trojanowski, and M.W. Weiner MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change Neurology 73 2009 294 301
14. P.J. Visser, F. Verhey, D.L. Knol, P. Scheltens, L.-O. Wahlund, and Y. Freund-Levi Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study Lancet Neurol 8 2009 619 627
15. K. Blennow, H. Hampel, M. Weiner, and H. Zetterberg Cerebrospinal fluid and plasma biomarkers in Alzheimer disease Nat Rev Neurol 6 2010 131 144
16. G. De Meyer, F. Shapiro, H. Vanderstichele, E. Vanmechelen, S. Engelborghs, and P.P. De Deyn Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people Arch Neurol 67 2010 949 956
17. C.R. Jack, H.J. Wiste, P. Vemuri, S.D. Weigand, M.L. Senjem, and G. Zeng Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease Brain 133 2010 3336 3348
18. S.M. Landau, M.A. Mintun, A.D. Joshi, R.A. Koeppe, R.C. Petersen, and P.S. Aisen Amyloid deposition, hypometabolism, and longitudinal cognitive decline Ann Neurol 72 2012 578 586
19. E.J. Golob, J.M. Ringman, R. Irimajiri, S. Bright, B. Schaffer, and L.D. Medina Cortical event-related potentials in preclinical familial Alzheimer disease Neurology 73 2009 1649 1655
20. G. Juckel, F. Clotz, T. Frodl, W. Kawohl, H. Hampel, and O. Pogarell Diagnostic usefulness of cognitive auditory event-related p300 subcomponents in patients with Alzheimers disease? J Clin Neurophysiol 25 2008 147 152
21. V.T. Papaliagkas, G. Anogianakis, M.N. Tsolaki, G. Koliakos, and V.K. Kimiskidis Combination of P300 and CSF β-amyloid(1-42) assays may provide a potential tool in the early diagnosis of Alzheimer's disease Curr Alzheimer Res 7 2010 295 299
22. J.W. Han, T.H. Kim, S.B. Lee, J.H. Park, J.J. Lee, and Y. Huh Predictive validity and diagnostic stability of mild cognitive impairment subtypes Alzheimers Dement 8 2012 553 559
23. C.R. Jack, F. Barkhof, M.A. Bernstein, M. Cantillon, P.E. Cole, and C. Decarli Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease Alzheimers Dement 7 2011 474 485.e4
24. V.K. Kimiskidis, and V.T. Papaliagkas Event-related potentials for the diagnosis of mild cognitive impairment and Alzheimer's disease Expert Opin Med Diagn 6 2012 15 26
25. K. Bennys, G. Rondouin, E. Benattar, A. Gabelle, and J. Touchon Can event-related potential predict the progression of mild cognitive impairment? J Clin Neurophysiol 28 2011 625 632
26. M. Wirth, C.M. Madison, G.D. Rabinovici, H. Oh, S.M. Landau, and W.J. Jagust Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals J Neurosci 33 2013 5553 5563
27. Cavedo, E and A Prestia, "Cognitive decline and cerebrospinal fluid biomarkers: a close relationship.,"2013.
28. B.C. Dickerson, and D. Wolk Biomarker-based prediction of progression in MCI: comparison of AD-signature and hippocampal volume with spinal fluid amyloid-β and tau Front Aging Neurosci 5 2013 55
29. L.G. Brooks, and D.A. Loewenstein Assessing the progression of mild cognitive impairment to Alzheimer's disease: current trends and future directions Alzheimers Res Ther 2 2010 28
30. P.J. Snyder, C.E. Jackson, R.C. Petersen, A.S. Khachaturian, J. Kaye, and M.S. Albert Assessment of cognition in mild cognitive impairment: a comparative study Alzheimers Dement 7 2011 338 355
31. H.B. Posner, S. Cano, M.C. Carrillo, O. Selnes, Y. Stern, and R.G. Thomas Establishing the psychometric underpinning of cognition measures for clinical trials of Alzheimer's disease and its precursors: a new approach Alzheimers Dement 9 2013 S56 S60
32. J. Hobart, S. Cano, H. Posner, O. Selnes, Y. Stern, and R. Thomas Putting the Alzheimer's cognitive test to the test II: Rasch Measurement Theory Alzheimers Dement 9 2013 S10 S20
33. K. Wild, D. Howieson, F. Webbe, A. Seelye, and J. Kaye Status of computerized cognitive testing in aging: a systematic review Alzheimers Dement 4 2008 428 437
34. P.E. Bailey, J.D. Henry, P.G. Rendell, L.H. Phillips, and M. Kliegel Dismantling the "age-prospective memory paradox": the classic laboratory paradigm simulated in a naturalistic setting Q J Exp Psychol (Hove) 63 2010 646 652
35. R.G. Knight, N. Titov, and M. Crawford The effects of distraction on prospective remembering following traumatic brain injury assessed in a simulated naturalistic environment J Int Neuropsychol Soc 12 2006 8 16
36. R.G. Knight, and N. Titov Use of virtual reality tasks to assess prospective memory: applicability and evidence Brain Impair 10 2009 3 13
37. P. Werner, S. Rabinowitz, E. Klinger, A.D. Korczyn, and N. Josman Use of the virtual action planning supermarket for the diagnosis of mild cognitive impairment: a preliminary study Dement Geriatr Cogn Disord 27 2009 301 309
38. I. Tarnanas, W. Schlee, M. Tsolaki, R. Müri, U. Mosimann, and T. Nef Ecological validity of virtual reality daily living activities screening for early dementia: longitudinal study JMIR Serious Games 1 2013 e1
39. B.C. Dickerson, A. Bakkour, D.H. Salat, E. Feczko, J. Pacheco, and D.N. Greve The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals Cereb Cortex 19 2009 497 510
40. R.C. Petersen, G.E. Smith, S.C. Waring, R.J. Ivnik, E.G. Tangalos, and E. Kokmen Mild cognitive impairment: clinical characterization and outcome Arch Neurol 56 1999 303 308
41. R.C. Oldfield The assessment and analysis of handedness: the Edinburgh inventory Neuropsychologia 9 1971 97 113
42. R.C. Petersen, J.C. Stevens, M. Ganguli, E.G. Tangalos, J.L. Cummings, and S.T. DeKosky Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 56 2001 1133 1142
43. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
44. E. Grober, H. Buschke, H. Crystal, S. Bang, and R. Dresner Screening for dementia by memory testing Neurology 38 1988 900 903
45. D. Wechsler MEM-III: Manuel de L'éhelle Clinique de Méoire Paris Les éditions du Cent Psychol 2001
46. B. Isaacs, and A.J. Akhtar The set test: a rapid test of mental function in old people Age Ageing 1 1972 222 226
47. T.N. Tombaugh Trail Making Test A and B: normative data stratified by age and education Arch Clin Neuropsychol 19 2 2004 203 214
48. G.A. Marshall, D.M. Rentz, M.T. Frey, J.J. Locascio, K.A. Johnson, and R.A. Sperling Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease Alzheimers Dement 7 2011 300 308
49. J. Polich, and K.L. Herbst P300 as a clinical assay: rationale, evaluation, and findings Int J Psychophysiol 38 2000 3 19
50. M.C. Carlson, Q.-L. Xue, J. Zhou, and L.P. Fried Executive decline and dysfunction precedes declines in memory: the Women's Health and Aging Study II J Gerontol A Biol Sci Med Sci 64 2009 110 117